NAP1L1
Nucleosome assembly protein 1-like 1
Also known as: MGC23410, MGC8688, NAP1, NAP1L, NP1L1_HUMAN, NRP
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P55209
- Gene
- NAP1L1
- Ensembl
- ENSG00000187109
- Chromosome
- 12
- Canonical length
- 391 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Microtubules
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes a member of the nucleosome assembly protein (NAP) family. This protein participates in DNA replication and may play a role in modulating chromatin formation and contribute to the regulation of cell proliferation. Alternative splicing results in multiple transcript variants encoding different isoforms; however, not all have been fully described. [provided by RefSeq, Apr 2015]
Canonical amino-acid sequenceUniProt
391 residues, UniProt reviewed canonical sequence.
>P55209|NAP1L1
1 MADIDNKEQS ELDQDLDDVE EVEEEETGEE TKLKARQLTV QMMQNPQILA ALQERLDGLV
61 ETPTGYIESL PRVVKRRVNA LKNLQVKCAQ IEAKFYEEVH DLERKYAVLY QPLFDKRFEI
121 INAIYEPTEE ECEWKPDEED EISEELKEKA KIEDEKKDEE KEDPKGIPEF WLTVFKNVDL
181 LSDMVQEHDE PILKHLKDIK VKFSDAGQPM SFVLEFHFEP NEYFTNEVLT KTYRMRSEPD
241 DSDPFSFDGP EIMGCTGCQI DWKKGKNVTL KTIKKKQKHK GRGTVRTVTK TVSNDSFFNF
301 FAPPEVPESG DLDDDAEAIL AADFEIGHFL RERIIPRSVL YFTGEAIEDD DDDYDEEGEE
361 ADEEGEEEGD EENDPDYDPK KDQNPAECKQ QLocalizationUniProt · AlphaFold · HPA
Whether an antibody against NAP1L1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.45
- Highest tissue expression
- 607 nTPM
Expression across tissuesHPA
Tissue
- ovary: 607 nTPM
- spinal cord: 447 nTPM
- lymph node: 426 nTPM
- skeletal muscle: 418 nTPM
- tonsil: 362 nTPM
- cervix: 352 nTPM
Single-cell type
- platelets: 4,031 nCPM
- megakaryocytes: 927 nCPM
- decidual stromal cells: 898 nCPM
- ovarian stromal cells: 867 nCPM
- esophageal basal cells: 808 nCPM
- peritubular myoid cells: 745 nCPM
Immune cell
- non-classical monocyte: 736 nTPM
- intermediate monocyte: 350 nTPM
- naive CD4 T-cell: 252 nTPM
- memory B-cell: 249 nTPM
- T-reg: 243 nTPM
- myeloid DC: 227 nTPM
Brain region
- spinal cord: 393 nTPM
- white matter: 353 nTPM
- thalamus: 328 nTPM
- basal ganglia: 327 nTPM
- medulla oblongata: 324 nTPM
- pons: 294 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.18
- gnomAD pLI
- 1
- gnomAD missense Z
- 1.76
- DepMap mean gene effect
- 0.02
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- DNA replication
- nervous system development
- nucleosome assembly
- positive regulation of cell population proliferation
- positive regulation of neural precursor cell proliferation
- positive regulation of neurogenesis
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of NAP1L1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads NAP1L1 as an antibody target. Whether an autoantibody or antibody against NAP1L1 could matter depends on whether native NAP1L1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
NAP1L1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label NAP1L1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...